TRVI position history
The shares of Trevi Therapeutics (TRVI) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q4: 485,000 shares, $936K, 0.33% of portfolio, New
- 2023 Q1: 835,800 shares, $1.5M, 0.46% of portfolio, Add +72.3%
- 2023 Q2: 1,701,500 shares, $4.1M, 0.97% of portfolio, Add +103.6%
- 2023 Q3: 1,705,900 shares, $3.7M, 1.2% of portfolio, Add +0.3%
- 2023 Q4: 2,535,000 shares, $3.4M, 0.90% of portfolio, Add +48.6%
- 2024 Q1: 5,290,000 shares, $18M, 4.1% of portfolio, Add +108.7%
- 2024 Q2: 2,645,000 shares, $7.9M, 1.8% of portfolio, Reduce −50.0%
- 2024 Q3: 2,567,990 shares, $8.6M, 1.4% of portfolio, Reduce −2.9%
- 2024 Q4: 2,317,500 shares, $9.5M, 1.7% of portfolio, Reduce −9.8%
- 2025 Q1: 795,000 shares, $5M, 1.1% of portfolio, Reduce −65.7%
- 2025 Q2: 780,000 shares, $4.3M, 0.86% of portfolio, Reduce −1.9%
- 2025 Q3: 390,000 shares, $3.6M, 0.50% of portfolio, Reduce −50.0%
- 2025 Q4: 690,200 shares, $8.6M, 1.1% of portfolio, Add +77.0%
- 2026 Q1: 345,100 shares, $4.1M, 0.54% of portfolio, Reduce −50.0%
- 2026 Q2: 310,000 shares, $5.8M, 0.52% of portfolio, Reduce −10.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|